Clinical trial Recruiting at 1 site Interventional Ages 18 and up

CommunityRx-Dpeer: peer-led support to help dementia caregivers connect with community resources

Official title: CommunityRx-Dementia + Peer Navigation (CRxDpeer): A Real-World Implementation and Effectiveness Study of an IT-Based Social Care Intervention

Run by University of Chicago · NCT07346183 · Data updated 2026-11-12

This program tests a peer navigator model to help dementia caregivers access personalized community resources and ongoing support over 12 months.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment330 (estimated)
SponsorUniversity of Chicago
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedOctober 5, 2026
Main results expectedFebruary 28, 2029
Study endsFebruary 28, 2029
Registry record updatedOctober 13, 2026
Trial IDNCT07346183 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adult informal caregivers of home-dwelling individuals with Alzheimer's disease or related dementias, residing in the study region, and with reliable phone, email, and consent to receive messages.

Probably not a fit

Caregivers who do not engage with the navigator or have limited access to needed resources may see little or no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The CRxDpeer program uses trained peer navigators to deliver education about social and caregiving needs, activate personalized resource lists, and provide ongoing navigation support through proactive text messages. Caregivers receive baseline resource information (HealtheRx) and coaching on communicating with service providers, plus 12 months of proactive follow-up. The intervention aims to leverage existing community assets to address social determinants of health and caregiver strain for home-dwelling individuals with Alzheimer's disease or related dementias. This approach builds on prior CommunityRx work and integrates technology-enabled, low-intensity navigation within a health-system framework. The study is led by the University of Chicago with collaboration from the NIA and involves participants residing in the target geographic area who are caregivers and have cell phone/text/email access.

Why it matters

Potential benefit: If successful, caregivers may experience better access to needed services and reduced stress through ongoing, proactive support.

How similar studies have gone: Prior CommunityRx trials have demonstrated feasibility and positive signals for navigator-based resource activation and social care integration.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Self-identifies as a caregiver of a home-dwelling person with Alzheimer's disease or related dementias (ADRD)
* Resides in the target geographic region of the study
* Has access to a cell phone and agrees to receive text messages from the study
* Has an email address that they can receive emails from
* Individuals under the age of 18 who are emancipated minors in the state of Illinois and a caregiver of a person with dementia

Exclusion Criteria:

* Minors who are not emancipated in the state of Illinois.
* Previously participated in the intervention arm of the CommunityRx-Dementia clinical trial

Where it's running

  • University of Chicago
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.